Pathogenesis (TB)
"Cell Envelope Biosynthesis in M. tuberculosis."
Published in TB and Outbreaks Week, May 17th, 1999
NIH Grant Number: 1K08AI01534-01. Grant Expires: June 30, 2003. Principle Investigator: Michael S. Glickman. Performing Organization: Yeshiva University, 500 W. 185th Street, New York, New York 10033. Description: "This proposal outlines a career development plan that consists of intensive research experience and didactic training in bacterial pathogenesis. The institutional environment is scientifically rich and well suited for the training of young physician-scientists. The ultimate goal of this period of intensive research training is to train the candidate as an independent investigator on a medical school faculty. Tuberculosis,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Vaccines (TB)
BCG Reactogenicity is an Overlooked Problem - Diagnostics (TB)
H37Rv Antibodies in CSF Don't Identify TB Meningitis - Immunity (TB)
Oxygen-, Nitrogen-Intermediates May Play Role in Resistance - Knowledge, Attitudes, Behavior
Families of Patients Must be Included in Counselling - Knowledge, Attitudes, Behavior
OSHA Respiratory Protection Complaints on Rise - Testing (TB)
Novel IS6110 Insertions Found in H37Ra Strain - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
